Cargando…
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
Wet media milling, coupled with spay drying, is a commonly proposed formulation strategy for the production and solidification of nanosuspensions in order to overcome the solubility barrier of BCS Class II substances. However, the application of mechanically and thermally intensive processes is not...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602516/ https://www.ncbi.nlm.nih.gov/pubmed/33066680 http://dx.doi.org/10.3390/pharmaceutics12100969 |
_version_ | 1783603699300433920 |
---|---|
author | Ouranidis, Andreas Gkampelis, Nikos Vardaka, Elisavet Karagianni, Anna Tsiptsios, Dimitrios Nikolakakis, Ioannis Kachrimanis, Kyriakos |
author_facet | Ouranidis, Andreas Gkampelis, Nikos Vardaka, Elisavet Karagianni, Anna Tsiptsios, Dimitrios Nikolakakis, Ioannis Kachrimanis, Kyriakos |
author_sort | Ouranidis, Andreas |
collection | PubMed |
description | Wet media milling, coupled with spay drying, is a commonly proposed formulation strategy for the production and solidification of nanosuspensions in order to overcome the solubility barrier of BCS Class II substances. However, the application of mechanically and thermally intensive processes is not straightforward in the cases of ductile and/or low melting point substances that may additionally be susceptible to eutectic formation. Using ibuprofen (IBU) as a model drug with non-favorable mechanical and melting properties, we attempt to rationalize nanocrystal formulation and manufacturing in an integrated approach by implementing Quality by Design (QbD) methodology, particle informatics techniques and computationally assisted process design. Wet media milling was performed in the presence of different stabilizers and co-milling agents, and the nanosuspensions were solidified by spray-drying. The effects of key process parameters (bead diameter, milling time and rotational speed) and formulation variables (stabilizer type and drug/stabilizer ratio) on the critical quality attributes (CQAs), i.e., Z-average size, polydispersity index (PDI), ζ-potential and redispersibility of spray-dried nanosuspensions were evaluated, while possible correlations between IBU free surface energy and stabilizer effectiveness were studied. The fracture mechanism and surface stabilization of IBU were investigated by computer simulation of the molecular interactions at the crystal lattice level. As a further step, process design accounting for mass-energy balances and predictive thermodynamic models were constructed to scale-up and optimize the design space. Contemplating several limitations, our multilevel approach offers insights on the mechanistic pathway applicable to the substances featuring thermosensitivity and eutectic tendency. |
format | Online Article Text |
id | pubmed-7602516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76025162020-11-01 Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation Ouranidis, Andreas Gkampelis, Nikos Vardaka, Elisavet Karagianni, Anna Tsiptsios, Dimitrios Nikolakakis, Ioannis Kachrimanis, Kyriakos Pharmaceutics Article Wet media milling, coupled with spay drying, is a commonly proposed formulation strategy for the production and solidification of nanosuspensions in order to overcome the solubility barrier of BCS Class II substances. However, the application of mechanically and thermally intensive processes is not straightforward in the cases of ductile and/or low melting point substances that may additionally be susceptible to eutectic formation. Using ibuprofen (IBU) as a model drug with non-favorable mechanical and melting properties, we attempt to rationalize nanocrystal formulation and manufacturing in an integrated approach by implementing Quality by Design (QbD) methodology, particle informatics techniques and computationally assisted process design. Wet media milling was performed in the presence of different stabilizers and co-milling agents, and the nanosuspensions were solidified by spray-drying. The effects of key process parameters (bead diameter, milling time and rotational speed) and formulation variables (stabilizer type and drug/stabilizer ratio) on the critical quality attributes (CQAs), i.e., Z-average size, polydispersity index (PDI), ζ-potential and redispersibility of spray-dried nanosuspensions were evaluated, while possible correlations between IBU free surface energy and stabilizer effectiveness were studied. The fracture mechanism and surface stabilization of IBU were investigated by computer simulation of the molecular interactions at the crystal lattice level. As a further step, process design accounting for mass-energy balances and predictive thermodynamic models were constructed to scale-up and optimize the design space. Contemplating several limitations, our multilevel approach offers insights on the mechanistic pathway applicable to the substances featuring thermosensitivity and eutectic tendency. MDPI 2020-10-14 /pmc/articles/PMC7602516/ /pubmed/33066680 http://dx.doi.org/10.3390/pharmaceutics12100969 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ouranidis, Andreas Gkampelis, Nikos Vardaka, Elisavet Karagianni, Anna Tsiptsios, Dimitrios Nikolakakis, Ioannis Kachrimanis, Kyriakos Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation |
title | Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation |
title_full | Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation |
title_fullStr | Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation |
title_full_unstemmed | Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation |
title_short | Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation |
title_sort | overcoming the solubility barrier of ibuprofen by the rational process design of a nanocrystal formulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602516/ https://www.ncbi.nlm.nih.gov/pubmed/33066680 http://dx.doi.org/10.3390/pharmaceutics12100969 |
work_keys_str_mv | AT ouranidisandreas overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation AT gkampelisnikos overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation AT vardakaelisavet overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation AT karagiannianna overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation AT tsiptsiosdimitrios overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation AT nikolakakisioannis overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation AT kachrimaniskyriakos overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation |